Search Results 2141-2150 of 21684 for platelets

1. Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer - Mayo Clinic

   Platelets >= 100,000/mcL; Total bilirubin within normal institutional limits; Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT])/ ...

2. Erlotinib with or without Bevacizumab in Treating Patients with Stage IV Non-Small Cell Lung Cancer with EGFR Mutations - Mayo Clinic

   Platelet count ≥ 100,000/mm^3; Hemoglobin ≥ 9.0 g/dL; Total bilirubin ≤ 1.5 x upper limit of normal (ULN); Serum glutamic oxaloacetic transaminase (SGOT) ...

3. Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery - Mayo Clinic

   - Platelets > 100,000/mcL. - Total bilirubin < 1.5 x institutional upper limit of normal (ULN). - Aspartate aminotransferase (AST) (serum glutamic ...

4. Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors - Mayo Clinic

   WBC ≥ 3000/UL and Platelet count ≥ 100,000/UL; Serum creatinine ≤ 1.5 mg/dL; Estimated GFR (by Cockcroft-Gault) ≥ 50mL/min; 12 or 24 hour urine creatinine ...

5. Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers - Mayo Clinic

   ... platelet count \< 100 x 109/L * QT interval corrected by Fridericia's formula (QTcF) ≥ 470 msec * Creatinine clearance \< 60 mL/min * Unmanageable urinary ...

6. Charles J. Bruce, M.B., Ch.B. - Doctors and Medical Staff - Mayo Clinic

   MemberClinical Events Committee, PURSUIT (Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy) Trial. 1994 ...

7. Statins for the Treatment of NASH - Mayo Clinic

   Platelets < 100 10^9 / L; 4. Hemoglobin < 10 g/dl; 5. Albumin < 3.5 g; 6. Prolonged international normalized ratio (INR); 7. Any elevation of bilirubin ...

8. Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer, TraPPer Study - Mayo Clinic

   -REGISTRATION: Hemoglobin >= 9.0 g/dL -REGISTRATION: Absolute neutrophil count (ANC) >= 1500/mm^3 -REGISTRATION: Platelet count >= 100,000/mm^3 ...

9. Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF) - Mayo Clinic

   Platelet count < 50 x10^9/L;; Hemoglobin < 8 g/dL (5 mmol/L at randomization, no ongoing bleeding, no blood transfusion of whole blood or red blood cells ...

10. Evaluating the safety and efficacy of mesenchymal stem cells in the treatment of low back pain - Mayo Clinic

    These therapies include intradiscal injections of biologic agents such as mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP), which are believed ...